<?xml version="1.0"?>

<document>
	<title>Spermine and spermidine, modulators of the cell surface enzyme
   adenylate cyclase.</title>

	<author>Wright-R-K.</author>
	<author>Buehler-B-A.</author>
	<author>Schott-S-N.</author>
	<author>Rennert-O-M.</author>

	<source>Pediatr-Res. 1978 Aug. 12(8). P 830-3.</source>

	<abstract>Adenylate cyclase activity was measured in membrane preparations of
   cultured fibroblasts from controls and patients with cystic fibrosis.
   Enzyme activity increased as the transition from exponential growth
   to confluence occurred; sodium fluoride-stimulated activity more
   markedly displayed this relationship than basal cyclase activity. The
   in vitro addition of spermine (1 X 10(-6) to 2 X 10(-3) M) to
   membrane preparations caused inhibition of basal and sodium fluoride-
   stimulated enzyme activity, with 50% inhibition of basal activity
   occurring at 10(-6) M spermine. Spermidine (10(-4) M) caused 15--25%
   inhibition of adenylate cyclase activity. The increase in fibroblast
   adenylate cyclase activity during the transition from exponential
   growth was comparable in cells obtained from cystic fibrosis patients
   and control subjects. Basal and sodium-fluoride stimulated adenylate
   cyclase activity as well as inhibition of this enzyme activity by
   spermidine and spermine were undistinguishable between the different
   cell genotypes. A potential modulation of cellular proliferative
   activity through polyamine interaction with the adenylate cyclase
   system is postulated.</abstract>

	<majorsubject>ADENYL-CYCLASE: ai</majorsubject>
	<majorsubject>CYSTIC-FIBROSIS: en</majorsubject>
	<majorsubject>SPERMIDINE: pd</majorsubject>
	<majorsubject>SPERMINE: pd</majorsubject>

	<minorsubject>ADULT</minorsubject>
	<minorsubject>CELL-MEMBRANE: de, en</minorsubject>
	<minorsubject>CELLS-CULTURED</minorsubject>
	<minorsubject>CHILD</minorsubject>
	<minorsubject>CHILD-PRESCHOOL</minorsubject>
	<minorsubject>COMPARATIVE-STUDY</minorsubject>
	<minorsubject>CYSTIC-FIBROSIS: pa</minorsubject>
	<minorsubject>FIBROBLASTS: de</minorsubject>
	<minorsubject>HUMAN</minorsubject>
	<minorsubject>IN-VITRO</minorsubject>
	<minorsubject>INFANT-NEWBORN</minorsubject>
	<minorsubject>SUPPORT-U-S-GOVT-P-H-S</minorsubject>

	<reference>001   ANDERSON WB           ADV CYCLIC NUCLEO RES            5   681 975</reference>
	<reference>002   AMATRUDA J            BIOCHIM BIOPHYS ACTA           373   266 974</reference>
	<reference>003   ARVANITAKIS S         TEX REP BIOL MED                34   175 976</reference>
	<reference>004   BUEHLER B             PEDIATR RES                     11   186 977</reference>
	<reference>005   BUCHWALD M            PROC NAT ACAD SCI USA           73  2899 976</reference>
	<reference>006   CHUN P                BIOCHEM BIOPHYS RES COMMUN      69  1095 976</reference>
	<reference>007   COHEN LF              PEDIATR RES                      9   334 975</reference>
	<reference>008   CUETRECASAS P         ADV CYCLIC NUCLEO RES            5    79 975</reference>
	<reference>009   DYKSTRA WG            SCIENCE                        149   428 965</reference>
	<reference>010   FRANKS DJ             FEBS LETTERS                    42   267 974</reference>
	<reference>011   HOLTTA E              BIOCHEM BIOPHYS RES COMMUN      54   350 973</reference>
	<reference>012   JOHNSON RA            J BIOL CHEM                    250  6599 975</reference>
	<reference>013   KOSSOROTOW A          BIOCHEM J                      144    21 974</reference>
	<reference>014   LOWRY OH              J BIOL CHEM                    193   265 951</reference>
	<reference>015   MANGOS JA             IN: MANGOS JA                        311 976</reference>
	<reference>016   ONEILL J              BIOCHIM BIOPHYS ACTA           404   243 975</reference>
	<reference>017   OTTEN J               J BIOL CHEM                    247  7082 972</reference>
	<reference>018   PROCTOR MS            J INVEST DERMATOL               65   409 975</reference>
	<reference>019   RAINA A               MED BIOL                        53   121 975</reference>
	<reference>020   RENNERT OM            TEX REP BIOL MED                34   187 976</reference>
	<reference>021   RICHARDS GM           ANAL BIOCHEM                    57   369 974</reference>
	<reference>022   ROSENTHAL S           BIOCHIM BIOPHYS ACTA           363   141 974</reference>
	<reference>023   RUSSELL DH            PROC NAT ACAD SCI USA           60  1420 968</reference>
	<reference>024   SALOMON Y             ANAL BIOCHEM                    58   541 974</reference>
	<reference>025   TASHIMA Y             BIOCHEM BIOPHYS RES COMMUN      66  1344 975</reference>
	<reference>026   WOLFF J               J BIOL CHEM                    250  6897 975</reference>
	<reference>027   WRIGHT RK             ARCH DERMATOL                  107    47 973</reference>

	<citation>1   ILLIANO G             BULL MOL BIOL MED                4   155 979</citation>
	<citation>2   CANELLAKIS ES         CURR TOP CELL REGUL             15   155 979</citation>
	<citation>3   TINTNER R             J NEUROCHEM                     33  1067 979</citation>
	<citation>4   ALLEN JC              EUR J BIOCHEM                  102   153 979</citation>
	<citation>5   GAHL WA               PEDIATR RES                     14   118 980</citation>
	<citation>6   KUROSHIMA A           JAP J PHYSIOL                   30   935 980</citation>
	<citation>7   KIMBERLY MM           ANAL CHEM                       53   789 981</citation>

</document>
